Health and Healthcare

Sorrento Therapeutics Wins FDA Approval to Proceed With COVID-19 Study

courtesy of the U.S. Food and Drug Administration

Sorrento Therapeutics Inc. (NASDAQ: SRNE) shares jumped on Thursday after the company announced that it received approval from the U.S. Food and Drug Administration (FDA) for its COVID-19 treatment.

The long and short of it was that the FDA issued a letter to Sorrento that it may proceed with its Phase 1 clinical trial for Covi-Guard (STI-1499) in hospitalized COVID-19 patients.

As Sorrento previously announced, in preclinical studies, STI-1499 demonstrated 100% in vitro neutralizing effect against SARS-CoV-2, preventing infection of healthy cells in such preclinical in vitro studies.

Separately, STI-1499 was further evaluated using multiple strains of SARS-CoV-2, including the highly contagious D614G variant. In these preclinical studies, the antibody has been 100% effective against the highly contagious D614G variant strain at similar doses to those observed in experiments with the USA-WA1/2020 strain.

At the same time, animal data generated in Syrian Golden hamsters infected with SARS-CoV-2 was presented to the FDA in support of a post-exposure human treatment dose for the IND.

The highest proposed dose (200 mg per patient) in the Phase 1 trial is a lower dose than currently being tested for other known SARS-CoV-2 targeted antibodies or antibody cocktails in active clinical studies. The potentially high potency of STI-1499 antibody may allow for rapid scaling up of manufacturing operations.

Sorrento Therapeutics stock traded up about 19% on Thursday, at $9.95 in a 52-week range of $1.39 to $19.39. The consensus price target is $24.00.

The Average American Is Losing Their Savings Every Day (Sponsor)

If you’re like many Americans and keep your money ‘safe’ in a checking or savings account, think again. The average yield on a savings account is a paltry .4% today, and inflation is much higher. Checking accounts are even worse.

Every day you don’t move to a high-yield savings account that beats inflation, you lose more and more value.

But there is good news. To win qualified customers, some accounts are paying 9-10x this national average. That’s an incredible way to keep your money safe, and get paid at the same time. Our top pick for high yield savings accounts includes other one time cash bonuses, and is FDIC insured.

Click here to see how much more you could be earning on your savings today. It takes just a few minutes and your money could be working for you.

 

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.